IHC is commentative in differentiating these subtypes, with DLBCL expressing CD20, PAX5, BCL-6, and CD10, whereas PBL typically lacks B-cell markers and expresses plasma cell markers such as CD38, CD138, and MUM1. The gene discussed is PAX5; the disease is diffuse large B-cell lymphoma.